z-logo
open-access-imgOpen Access
Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors
Author(s) -
Seyed Mohammad Kazem Aghamir,
Ramin Heshmat,
Mehdi Ebrahimi,
Fatemeh Khatami
Publication year - 2020
Publication title -
epigenetics insights
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.039
H-Index - 4
ISSN - 2516-8657
DOI - 10.1177/2516865720904052
Subject(s) - liquid biopsy , nucleic acid , biopsy , microvesicles , pathology , dna , cancer , biology , cell free fetal dna , circulating tumor cell , cancer cell , cancer research , medicine , microrna , genetics , gene , metastasis , pregnancy , fetus , prenatal diagnosis
Blood test is a kind of liquid biopsy that checks cancer cells or cancer nucleic acids circulating freely from cells in the blood. A liquid biopsy may be used to distinguish cancer at early stages and it could be a game-changer for both cancer diagnosis and prognosis strategies. Liquid biopsy tests consider several tumor components, such as DNA, RNA, proteins, and the tiny vesicles originating from tumor cells. Actually, liquid biopsy signifies the genetic alterations of tumors through nucleic acids or cells in various body fluids, including blood, urine, cerebrospinal fluid, or saliva in a noninvasive manner. In this review, we present an overall description of liquid biopsy in which circulating tumor cells, cell-free nucleic acids, exosomes, and extrachromosomal circular DNA are included.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom